Omnicell is trading at $34.76, up +5.08%, after BlackRock disclosed acquiring more than 7.5 million shares during the second quarter, creating a 16.58% stake.
- The disclosure follows a recent earnings beat: non-GAAP earnings reached $0.94 per share versus expectations of $0.42, while revenue was $312.21 million versus $304.83 million.
- Major U.S. indexes are lower, suggesting company-specific buying rather than broad market strength.